Recommendations and Reports: Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 Influenza Season
This report describes ACIP recommendations for use of seasonal influenza vaccines during the 2022-23 season in the U.S. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - August 25, 2022 Category: American Health Tags: Advisory Committee on Immunization Practices (ACIP) Influenza (Flu) Influenza Vaccination MMWR Morbidity & Mortality Weekly Report Source Type: news
A warming planet could mess with our sleep – and make us more vulnerable to infectious diseases
Key takeaways:Heat spoils sleep. Studies have shown that higher temperatures contribute to sleep disturbance, said Dr. Michael Irwin, who reviewed a wide body of research for the current paper.Poor sleep harms health. Studies also show that a lack of sleep can reduce our immune response and heighten our risk of infection.The big question:Considering these factors, is it possible the ongoing climate crisis may play a role in our susceptibility to COVID-19, monkeypox and other infectious diseases? It ’s a scene that will be familiar for many after yet another scorching summer: You’re lying awake during a warm ...
Source: UCLA Newsroom: Health Sciences - August 24, 2022 Category: Universities & Medical Training Source Type: news
Expect a different flu season: Why you'll want to be vaccinated for flu
COVID-19 may be the most prominent virus of concern in the U.S. now, but public health officials also are preparing for seasonal influenza. And indications are it could be a different season than what the U.S. experienced the past two years. The Australian flu season, which typically runs May through September, has already exceeded its five-year average, particularly affecting children under age 5, according to a recent report. During the height of the COVID-19 pandemic, the U.S. experienced a steep… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - August 23, 2022 Category: Databases & Libraries Source Type: news
The Best Time To Get Your 2022 Flu Shot, According To A Vaccine Expert
Want the best protection this season? You may want to get your influenza shot earlier than you think. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - August 22, 2022 Category: Consumer Health News Source Type: news
Seasonal influenza vaccination programme
The seasonal flu enhanced service specification 1 September 2022 to 31 March 2023 is directed at general practice to offer and provide flu vaccinations to eligible cohorts as outlined within this specification. (Source: NHS Networks)
Source: NHS Networks - August 22, 2022 Category: UK Health Source Type: news
WHO and UDER implement multi-partner project to boost primary health care services in northwest ...
21 August 2022 – WHO, together with the Relief Experts Association UDER as implementing agency, has bolstered the provision of primary health care services in northwest Syria by rendering the facilities in the towns of Sarmada, Tarmanin, Daret Azza and Zarzour fully operational.
Due to the size and scope of the project – which took place between August 2021 and May 2022 – UDER had struck agreements with several other organizations on the ground. Thanks to immense efforts requiring daily coordination, the Mentor Initiative offered leishmaniasis treatment services; Physicians Across Continents delivered mal...
Source: WHO EMRO News - August 21, 2022 Category: Middle East Health Source Type: news
Community pharmacy flu vaccine service
NHS England has published the service specification for the community pharmacy seasonal influenza vaccine advanced service for the 2022/23 flu season. (Source: NHS Networks)
Source: NHS Networks - August 19, 2022 Category: UK Health Source Type: news
Getting A Grip On Influenza: The Pursuit Of A Universal Vaccine (Part 2)
Although decent, our current influenza vaccines are not as effective as they ought to be. Part of the issue may have to do with the production process. Are recent changes enough to improve effectiveness? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 18, 2022 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news
Flucelvax Quadrivalent 2016-2017 Formula (Influenza Vaccine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 16, 2022 Category: Drugs & Pharmacology Source Type: news
Text Message Reminders Promote Receipt of Second Flu Shot
MONDAY, Aug. 15, 2022 -- Text message reminders effectively promote receipt of a second dose of influenza vaccine among children, according to a study published online Aug. 15 in Pediatrics.
Melissa S. Stockwell, M.D., M.P.H., from Columbia... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 15, 2022 Category: Pharmaceuticals Source Type: news
British Regulators Authorize Moderna ’ s Updated COVID-19 Booster
LONDON — British drug regulators have become the first in the world to authorize an updated version of Moderna’s coronavirus vaccine that aims to protect against the original virus and the Omicron variant.
In a statement on Monday, the Medicines and Healthcare Regulatory Agency said it had given the green light to Moderna’s combination “bivalent” vaccine, which will be used as an adult booster shot.
Each dose of the booster shot will target both the original COVID-19 virus that was first detected in 2020 and the Omicron BA.1 variant that was first picked up in November. British regulators said...
Source: TIME: Health - August 15, 2022 Category: Consumer Health News Authors: Maria Cheng/AP Tags: Uncategorized COVID-19 healthscienceclimate wire Source Type: news
Getting A Grip On Influenza: The Pursuit Of A Universal Vaccine (Part 1)
Influenza A viruses continue to cause seasonal outbreaks year in and year out. Developing a broadly neutralizing vaccine effective against all subtypes has proven challenging. Here, I explain why this is. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 12, 2022 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news
Roche announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and older
Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved in the US for children as young as five years of ageThe FDA also approved Xofluza to prevent influenza in children aged five years and older following contact with an infected personBasel, 12 August 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Xofluza ® (baloxavir marboxil) for the treatment of acute uncomplicated influenza in otherwise healthy children aged five to less than 12 years o...
Source: Roche Investor Update - August 12, 2022 Category: Pharmaceuticals Source Type: news
Roche announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and older
Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved in the US for children as young as five years of ageThe FDA also approved Xofluza to prevent influenza in children aged five years and older following contact with an infected personBasel, 12 August 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Xofluza ® (baloxavir marboxil) for the treatment of acute uncomplicated influenza in otherwise healthy children aged five to less than 12 years o...
Source: Roche Media News - August 12, 2022 Category: Pharmaceuticals Source Type: news
With Innovation, We Can Keep Reducing the Toll of COVID-19
Scrolling through social media these days, you’ll see that loud extremists continue to dominate COVID-19 discourse. At one pole are the denialists who argue—incorrectly—that COVID is “just a cold.” At the other are those who suggest that no meaningful progress has been made in controlling its devastation. The truth, of course, is somewhere in the middle.
We have not yet extricated ourselves from the peril of SARS-CoV-2, and wishing COVID-19 gone does not make it so. Surging case numbers provide opportunities to produce the next variant as the virus evolves to escape antibodies accumulated from...
Source: TIME: Health - August 9, 2022 Category: Consumer Health News Authors: Edward Nirenberg, Gavin Yamey and Ilan Schwartz Tags: Uncategorized COVID-19 freelance Source Type: news
